An Integrated Glycosylation Signature of Rheumatoid Arthritis

Rheumatoid arthritis (RA) Is a highly prevalent autoimmune disease that affects the joints but also various other organs. The disease is characterized by autoantibodies that are often already observed pre-disease. Since the 1980s, it has been known that antibody glycosylation is different in RA as c...

Full description

Bibliographic Details
Main Authors: Oleg A. Mayboroda, Guinevere S. M. Lageveen-Kammeijer, Manfred Wuhrer, Radboud J. E. M. Dolhain
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/7/1106
_version_ 1797590104503484416
author Oleg A. Mayboroda
Guinevere S. M. Lageveen-Kammeijer
Manfred Wuhrer
Radboud J. E. M. Dolhain
author_facet Oleg A. Mayboroda
Guinevere S. M. Lageveen-Kammeijer
Manfred Wuhrer
Radboud J. E. M. Dolhain
author_sort Oleg A. Mayboroda
collection DOAJ
description Rheumatoid arthritis (RA) Is a highly prevalent autoimmune disease that affects the joints but also various other organs. The disease is characterized by autoantibodies that are often already observed pre-disease. Since the 1980s, it has been known that antibody glycosylation is different in RA as compared to control individuals. While the literature on glycosylation changes in RA is dominated by reports on serum or plasma immunoglobulin G (IgG), our recent studies have indicated that the glycosylation changes observed for immunoglobulin A (IgA) and total serum <i>N</i>-glycome (TSNG) may be similarly prominent, and useful in differentiating between the RA patients and controls, or as a proxy of the disease activity. In this study, we integrated and compared the RA glycosylation signatures of IgG, IgA and TSNG, all determined in the pregnancy-induced amelioration of rheumatoid arthritis (PARA) cohort. We assessed the association of the altered glycosylation patterns with the disease, autoantibody positivity and disease activity. Our analyses indicated a common, composite glycosylation signature of RA that was independent of the autoantibody status.
first_indexed 2024-03-11T01:15:41Z
format Article
id doaj.art-79a86f34bd434b6e81166a0faf03f613
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-11T01:15:41Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-79a86f34bd434b6e81166a0faf03f6132023-11-18T18:31:31ZengMDPI AGBiomolecules2218-273X2023-07-01137110610.3390/biom13071106An Integrated Glycosylation Signature of Rheumatoid ArthritisOleg A. Mayboroda0Guinevere S. M. Lageveen-Kammeijer1Manfred Wuhrer2Radboud J. E. M. Dolhain3Center for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The NetherlandsCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The NetherlandsCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The NetherlandsDepartment of Rheumatology, Erasmus Medical Center, 3015 CN Rotterdam, The NetherlandsRheumatoid arthritis (RA) Is a highly prevalent autoimmune disease that affects the joints but also various other organs. The disease is characterized by autoantibodies that are often already observed pre-disease. Since the 1980s, it has been known that antibody glycosylation is different in RA as compared to control individuals. While the literature on glycosylation changes in RA is dominated by reports on serum or plasma immunoglobulin G (IgG), our recent studies have indicated that the glycosylation changes observed for immunoglobulin A (IgA) and total serum <i>N</i>-glycome (TSNG) may be similarly prominent, and useful in differentiating between the RA patients and controls, or as a proxy of the disease activity. In this study, we integrated and compared the RA glycosylation signatures of IgG, IgA and TSNG, all determined in the pregnancy-induced amelioration of rheumatoid arthritis (PARA) cohort. We assessed the association of the altered glycosylation patterns with the disease, autoantibody positivity and disease activity. Our analyses indicated a common, composite glycosylation signature of RA that was independent of the autoantibody status.https://www.mdpi.com/2218-273X/13/7/1106glycosylationrheumatoid arthritisantibody
spellingShingle Oleg A. Mayboroda
Guinevere S. M. Lageveen-Kammeijer
Manfred Wuhrer
Radboud J. E. M. Dolhain
An Integrated Glycosylation Signature of Rheumatoid Arthritis
Biomolecules
glycosylation
rheumatoid arthritis
antibody
title An Integrated Glycosylation Signature of Rheumatoid Arthritis
title_full An Integrated Glycosylation Signature of Rheumatoid Arthritis
title_fullStr An Integrated Glycosylation Signature of Rheumatoid Arthritis
title_full_unstemmed An Integrated Glycosylation Signature of Rheumatoid Arthritis
title_short An Integrated Glycosylation Signature of Rheumatoid Arthritis
title_sort integrated glycosylation signature of rheumatoid arthritis
topic glycosylation
rheumatoid arthritis
antibody
url https://www.mdpi.com/2218-273X/13/7/1106
work_keys_str_mv AT olegamayboroda anintegratedglycosylationsignatureofrheumatoidarthritis
AT guineveresmlageveenkammeijer anintegratedglycosylationsignatureofrheumatoidarthritis
AT manfredwuhrer anintegratedglycosylationsignatureofrheumatoidarthritis
AT radboudjemdolhain anintegratedglycosylationsignatureofrheumatoidarthritis
AT olegamayboroda integratedglycosylationsignatureofrheumatoidarthritis
AT guineveresmlageveenkammeijer integratedglycosylationsignatureofrheumatoidarthritis
AT manfredwuhrer integratedglycosylationsignatureofrheumatoidarthritis
AT radboudjemdolhain integratedglycosylationsignatureofrheumatoidarthritis